Skip to main content
TipRanks
Go Ultimate75% OFF

Caliway Biopharmaceuticals Co Ltd (6919) Cash flow

Caliway Biopharmaceuticals Co Ltd Cash Flow

TW:6919's free cash flow for Q2 2026 was NT$-134.54M. For the 2026 fiscal year, TW:6919's free cash flow was decreased by NT$-5.43M and operating cash flow was NT$-129.10M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ -425.90MNT$ -522.31MNT$ -423.94MNT$ -242.76MNT$ -110.55M
NT$ -5.62BNT$ -2.49BNT$ 157.09MNT$ -470.54MNT$ -14.88M
NT$ -119.11MNT$ 6.49BNT$ 3.03BNT$ 771.72MNT$ 625.98M
NT$ 784.44MNT$ 6.90BNT$ 3.42BNT$ 655.05MNT$ 594.12M
NT$ -443.04MNT$ -533.40MNT$ -433.62MNT$ -256.93MNT$ -125.43M

Currency in TWD

Caliway Biopharmaceuticals Co Ltd Cash Flow

-7.5B-5B-2.5B02.5B5B7.5B2019202020212022202320242025OperatingInvestingFinancing